Compare Quest Diagnostics Inc (DGX) vs Shopify Inc. (SHOP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Shopify Inc. — how do they compare? Quest Diagnostics Inc trades at $229.97 (market cap $25.48B), while Shopify Inc. trades at $170.62 (market cap $211.73B). The key difference: Shopify Inc. is far larger — about 8.3× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while Shopify Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Shopify Inc. for 78 Days on average.
| DGX | SHOP | |
|---|---|---|
Market Cap | $25.48B | $211.73B |
Volume | 941,866 | 7,146,651 |
Sector | Health | Technology |
52-Week High | $247.45 | $179.01 |
52-Week Low | $173.49 | $95.40 |
Typical Hold Time | 56 Days | 78 Days |
Enterprise Value | $31.23B | $206.96B |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.97, up 1.75% today, with a technical bias leaning bearish despite recent earnings beats. Revenue grew to $11.04B in 2025, with net income reaching $992M, though profit margins have moderated. Analyst consensus is a $250 price target with a mixed buy/hold sentiment. Recent news highlights growth in consumer testing and partnerships, alongside concerns over potential Medicare reimbursement cuts.
The outlook balances solid fundamentals and growth initiatives against regulatory risks. Upside potential exists from continued operational execution and new ventures like the Apple Health app integration, but investors face headwinds from reimbursement uncertainty and a high debt load. The stock's valuation appears reasonable relative to peers, supporting a cautious but opportunistic view.
Shopify (SHOP) trades at $170.85, up 2.96% today, showing strong momentum near its 52-week high. The stock exhibits bullish technical signals with positive moving averages, though RSI levels suggest potential overbought conditions. Fundamentally, Shopify demonstrates robust revenue growth from $5.6B in 2022 to $11.6B in 2025, with net income turning positive and reaching $1.23B. Recent earnings show mixed results with one miss and two beats in the last three quarters.
Shopify's outlook remains positive with accelerating merchant solutions growth and AI innovations, though elevated valuation metrics (P/E of 111.19) present risk. Analyst consensus is strongly bullish with 67% buy ratings and $168.63 price target. Key risks include competitive pressures from Amazon and valuation sensitivity to growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →
